Evidence map›Paper›PMID 42100530›Full record

ArticleFrontiers in public health2026

Factors influencing PrEP adoption in sexual health clinics within Ontario's public health system: a qualitative study using the Consolidated Framework for Implementation Research (CFIR).

Emma Nagy, Beatriz Alvarado, Carmela Rapino, Oluwatoyosi Kuforiji, Nicholas Cofie, Bradley Stoner, Nancy Dalgarno, Pilar Camargo-Plazas, T Hugh Guan, Jorge Martinez-Cajas

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emma NagySoutheast Public Health, Kingston, ON, Canada.
Beatriz AlvaradoDepartment of Public Health Sciences, Queen's University, Kingston, ON, Canada.
Carmela RapinoSoutheast Public Health, Kingston, ON, Canada.
Oluwatoyosi KuforijiOffice of Professional Development and Educational Scholarship, Queen's University, Kingston, ON, Canada.
Nicholas CofieOffice of Professional Development and Educational Scholarship, Queen's University, Kingston, ON, Canada.
Bradley StonerDepartment of Public Health Sciences, Queen's University, Kingston, ON, Canada.
Nancy DalgarnoOffice of Professional Development and Educational Scholarship, Queen's University, Kingston, ON, Canada.
Pilar Camargo-PlazasSchool of Nursing, Queen's University, Kingston, ON, Canada.
T Hugh GuanDivision of Infectious Diseases, Department of Medicine, Queen's University, Kingston, ON, Canada.
Jorge Martinez-CajasDivision of Infectious Diseases, Department of Medicine, Queen's University, Kingston, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: HIV pre-exposure prophylaxis (PrEP) utilization in Ontario is concentrated in two large urban centers, resulting in geographic and structural inequities in access. Little is known about adoption in Public Health Sexual Health Clinics (PHSHCs) or the implementation factors influencing uneven uptake. This study aimed to: (1) assess the extent of PrEP adoption in PHSHCs; (2) identify barriers and facilitators affecting implementation; and (3) explore factors supporting successful and equitable PrEP implementation. Methods: Semi-structured interviews were conducted with 18 staff and managers across 12 PHSHCs. The Consolidated Framework for Implementation Research (CFIR) guided data collection and analysis, while the Health Equity Implementation Framework (HEIF) was applied to examine structural, organizational, and socio-cultural influences on PrEP access. Clinics were categorized into five adoption categories using the diffusion of innovations model. A content analysis was done to identify common facilitators, barriers, and equity-relevant factors distinguishing clinics at different adoption categories. Results: PrEP adoption varied widely across clinics. Two were innovators, providing on-site PrEP; three were early adopters with formal referral pathways; four were early majority, relying on informal referrals; and five lacked established services. Facilitators included strong PrEP knowledge and beliefs, inter-organizational partnerships, and supportive organizational cultures. Key barriers were post-COVID-19 service recovery constraints, limited external prescribers, insufficient medication funding, constrained internal capacity, and social individual-level barriers. Differences between advanced and less advanced adopters reflected perceived relative advantage of PrEP within PHSHC mandates, workflow integration complexity, and the presence of a supportive learning climate. Equity-focused analysis highlighted obstacles affecting clients experiencing socioeconomic disadvantage, rurality, stigma, and limited healthcare navigation capacity. Conclusion: This study highlights that inequities in PrEP access across Ontario PHSHCs are shaped not only by clinic readiness but also by broader structural and organizational conditions. These findings advance understanding of PrEP adoption outside large urban centers, identifying barriers and strategies to expand services and enhance implementation readiness. Using the CFIR and HEIF, we delineated factors to support adoption in early-stage PHSHCs while learning from those with successful integration. Addressing these factors will be critical to expanding equitable access to PrEP and advancing HIV prevention goals.

Indexed as

Ambulatory Care FacilitiesHIV InfectionsPre-Exposure ProphylaxisSexual HealthFemaleHealth Services AccessibilityHumansInterviews as TopicOntarioQualitative ResearchHIVHIV PrEPHIV preventionPrEP adoptionpublic healthsexual health clinics

Identifiers

PMID42100530
PMCPMC13144111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.